(UMC) United Microelectronics - Ratings and Ratios
Semiconductor, Wafers, Integrated Circuits, Foundry Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.16% |
| Yield on Cost 5y | 8.01% |
| Yield CAGR 5y | 14.10% |
| Payout Consistency | 73.5% |
| Payout Ratio | 93.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 29.1% |
| Value at Risk 5%th | 45.7% |
| Relative Tail Risk | -4.43% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.80 |
| Alpha | 12.24 |
| CAGR/Max DD | 0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.478 |
| Beta | 0.863 |
| Beta Downside | 0.576 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.00% |
| Mean DD | 11.35% |
| Median DD | 9.78% |
Description: UMC United Microelectronics December 19, 2025
United Microelectronics Corporation (UMC) is a pure-play semiconductor wafer foundry headquartered in Hsinchu, Taiwan, with manufacturing footprints across Asia, the United States and Europe. The firm produces integrated circuits for mobile, IoT, computing, automotive and data-processing applications, and supplements its core fab services with backend design support, venture-capital backing, consulting, and R&D offerings.
Key metrics as of FY 2023: revenue of roughly $9.5 billion, a global foundry market share of about 5 % (focused on mature nodes such as 28 nm-40 nm), and an average fab utilization of ≈ 87 % in Q3 2024. UMC’s capacity expansion plan adds ~200,000 wafers per month through new 300 mm lines slated for 2025, positioning the company to capture rising demand from AI-driven data-center workloads and automotive electronics while navigating US-China trade constraints.
For a deeper quantitative assessment of UMC’s valuation and risk profile, see the detailed analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (40.16b TTM) > 0 and > 6% of Revenue (6% = 14.17b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA 9.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 46.83% (prev 46.43%; Δ 0.40pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.18 (>3.0%) and CFO 99.84b > Net Income 40.16b (YES >=105%, WARN >=100%) |
| Net Debt (-28.31b) to EBITDA (103.70b) ratio: -0.27 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.34 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.52b) change vs 12m ago 0.16% (target <= -2.0% for YES) |
| Gross Margin 28.92% (prev 32.69%; Δ -3.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 41.80% (prev 39.51%; Δ 2.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 28.47 (EBITDA TTM 103.70b / Interest Expense TTM 1.66b) >= 6 (WARN >= 3) |
Altman Z'' 4.80
| (A) 0.20 = (Total Current Assets 192.85b - Total Current Liabilities 82.28b) / Total Assets 555.40b |
| (B) 0.33 = Retained Earnings (Balance) 181.24b / Total Assets 555.40b |
| (C) 0.08 = EBIT TTM 47.23b / Avg Total Assets 564.84b |
| (D) 1.78 = Book Value of Equity 346.07b / Total Liabilities 194.20b |
| Total Rating: 4.80 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.51
| 1. Piotroski 6.50pt |
| 2. FCF Yield 7.31% |
| 3. FCF Margin 19.69% |
| 4. Debt/Equity 0.21 |
| 5. Debt/Ebitda -0.27 |
| 6. ROIC - WACC (= 3.05)% |
| 7. RoE 10.95% |
| 8. Rev. Trend -43.73% |
| 9. EPS Trend -79.66% |
What is the price of UMC shares?
Over the past week, the price has changed by -2.24%, over one month by +0.77%, over three months by +7.54% and over the past year by +27.54%.
Is UMC a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 3
- Sell: 2
- Strong Sell: 0
What are the forecasts/targets for the UMC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 6.5 | -17.5% |
| Analysts Target Price | 6.5 | -17.5% |
| ValueRay Target Price | 8.7 | 11.2% |
UMC Fundamental Data Overview December 28, 2025
P/E Trailing = 14.8519
P/E Forward = 13.0548
P/S = 0.0855
P/B = 1.7627
P/EG = 1.535
Beta = 0.945
Revenue TTM = 236.13b TWD
EBIT TTM = 47.23b TWD
EBITDA TTM = 103.70b TWD
Long Term Debt = 53.76b TWD (from longTermDebt, last quarter)
Short Term Debt = 16.70b TWD (from shortTermDebt, last quarter)
Debt = 75.91b TWD (from shortLongTermDebtTotal, last quarter)
Net Debt = -28.31b TWD (from netDebt column, last quarter)
Enterprise Value = 635.99b TWD (633.67b + Debt 75.91b - CCE 73.59b)
Interest Coverage Ratio = 28.47 (Ebit TTM 47.23b / Interest Expense TTM 1.66b)
FCF Yield = 7.31% (FCF TTM 46.49b / Enterprise Value 635.99b)
FCF Margin = 19.69% (FCF TTM 46.49b / Revenue TTM 236.13b)
Net Margin = 17.01% (Net Income TTM 40.16b / Revenue TTM 236.13b)
Gross Margin = 28.92% ((Revenue TTM 236.13b - Cost of Revenue TTM 167.84b) / Revenue TTM)
Gross Margin QoQ = 29.81% (prev 28.72%)
Tobins Q-Ratio = 1.15 (Enterprise Value 635.99b / Total Assets 555.40b)
Interest Expense / Debt = 0.60% (Interest Expense 454.1m / Debt 75.91b)
Taxrate = -2.05% (negative due to tax credits) (-300.3m / 14.64b)
NOPAT = 48.20b (EBIT 47.23b * (1 - -2.05%)) [negative tax rate / tax credits]
Current Ratio = 2.34 (Total Current Assets 192.85b / Total Current Liabilities 82.28b)
Debt / Equity = 0.21 (Debt 75.91b / totalStockholderEquity, last quarter 361.06b)
Debt / EBITDA = -0.27 (Net Debt -28.31b / EBITDA 103.70b)
Debt / FCF = -0.61 (Net Debt -28.31b / FCF TTM 46.49b)
Total Stockholder Equity = 366.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.23% (Net Income 40.16b / Total Assets 555.40b)
RoE = 10.95% (Net Income TTM 40.16b / Total Stockholder Equity 366.62b)
RoCE = 11.24% (EBIT 47.23b / Capital Employed (Equity 366.62b + L.T.Debt 53.76b))
RoIC = 11.33% (NOPAT 48.20b / Invested Capital 425.47b)
WACC = 8.28% (E(633.67b)/V(709.58b) * Re(9.20%) + D(75.91b)/V(709.58b) * Rd(0.60%) * (1-Tc(-0.02)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF Debug] Terminal Value 65.40% ; FCFE base≈46.49b ; Y1≈30.52b ; Y5≈13.96b
Fair Price DCF = 90.69 (DCF Value 228.34b / Shares Outstanding 2.52b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -79.66 | EPS CAGR: -5.46% | SUE: 2.80 | # QB: 1
Revenue Correlation: -43.73 | Revenue CAGR: 0.01% | SUE: 0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.11 | Chg30d=+0.012 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=0.52 | Chg30d=-0.029 | Revisions Net=+0 | Growth EPS=-5.3% | Growth Revenue=+6.3%
Additional Sources for UMC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle